Strata Critical Medical, Inc. (SRTA)
5.345
+0.02
(+0.28%)
USD |
NASDAQ |
May 07, 16:00
5.345
0.00 (0.00%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 464.96M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 93.12% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 1.790 |
| Price to Book Value | 1.627 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0156 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 88.82% |
Profile
| Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the United States healthcare industry. It operates through the following segments: Logistics and Clinical. The Logistics segment includes Organ Placement, Air, and Ground Logistics. The Clinical segment focuses on Organ Recovery, Normothermic Regional Perfusion, Preservation, and Cardiac Care. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY. |
| URL | http://www.stratacritical.com |
| Investor Relations URL | https://ir.stratacritical.com/ |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | May. 06, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the United States healthcare industry. It operates through the following segments: Logistics and Clinical. The Logistics segment includes Organ Placement, Air, and Ground Logistics. The Clinical segment focuses on Organ Recovery, Normothermic Regional Perfusion, Preservation, and Cardiac Care. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY. |
| URL | http://www.stratacritical.com |
| Investor Relations URL | https://ir.stratacritical.com/ |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | May. 06, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
